| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |